Global CDC7 Kinase Inhibitors Clinical Trials & Market Opportunity Insight Report 2024: Combining CDC7 Kinase Inhibitors with Existing Cancer Therapies for Enhanced Efficacy
January 11, 2024 05:28 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global CDC7 Kinase Inhibitors Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Tyrosine Kinase Inhibitors Global Market Forecast and Trends 2023-2028
December 19, 2023 04:38 ET
|
Research and Markets
Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Tyrosine Kinase Inhibitors: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. This report presents an in-depth...
Itacitinib Emerging Drug Insight and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
December 07, 2023 09:08 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "Itacitinib Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Netarsudil for Fuchs Endothelial Corneal Dystrophy (FECD), 2019-2023 Emerging Drug Insights and Forecasts to 2032
November 23, 2023 11:18 ET
|
Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "Netarsudil Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "Netarsudil Emerging Drug...
Global Cyclin-Dependent Kinase Inhibitor Drug Pipeline Research Report 2023: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type
November 20, 2023 10:28 ET
|
Research and Markets
Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent...
JAK Inhibitors Market Surges as Autoimmune Diseases Demand Cutting-Edge Solutions, 2032F: Revenues for Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, and Other Inhibitor Types
November 01, 2023 08:18 ET
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Janus Kinase (JAK) Inhibitors Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global Janus Kinase (JAK)...
AMO-02 Emerging Drug Insights and Market Forecasts, 2032: Focus on 7 Major Markets - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
August 03, 2023 06:48 ET
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "AMO-02 Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. The report offers...
Global Recombinant Proteins Market Report 2023 - 2033: Patent Expiration for Biologics Drives Growth
July 10, 2023 04:08 ET
|
Research and Markets
Dublin, July 10, 2023 (GLOBE NEWSWIRE) -- The "Recombinant Proteins Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.This report will prove invaluable to leading...
Global BCR ABL Tyrosine Kinase Inhibitor Drug Market to 2029: Players Include Terns Pharmaceuticals, Theseus Pharmaceuticals, Vectura and Xspray Pharma
July 06, 2023 05:03 ET
|
Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Global BCR ABL Tyrosine Kinase Inhibitor Drug Market, Drug Price, Sales & Clinical Trials Insight 2029" report has been added to ...
Zunsemetinib (ATI-450) Emerging Drug Insights and Market Forecasts, 2032
April 13, 2023 10:33 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report...